Vincerx Pharma Inc
NASDAQ:VINC

Watchlist Manager
Vincerx Pharma Inc Logo
Vincerx Pharma Inc
NASDAQ:VINC
Watchlist
Price: 0.058 USD -14.71% Market Closed
Market Cap: 303.3k USD

During the last 3 months Vincerx Pharma Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 96% over this period (open performance analysis).

The last transaction was made on Aug 11, 2023 by Seelenberger Alexander A. , who bought 10k USD worth of VINC shares.

Last Transactions:
Seelenberger Alexander A.
$+498.4
Thomas Tom C
$+237.5
Hamdy Ahmed Md
$+799.7
Izumi Raquel E.
$+586.9
Izumi Raquel E.
$+1.3k
Thomas Tom C
$+290.5
Hamdy Ahmed Md
$+1.5k
Lowe Christopher P.
$+1.5k
Izumi Raquel E.
$+2.8k
Hamdy Ahmed Md
$+1.7k
Bushnell Laura I.
$+1.4k
Hwang Sooin
$+1.5k
Thomas Tom C
$+511.5
Hamdy Ahmed Md
$+3.2k
Seelenberger Alexander A.
$+1.3k
Bushnell Laura I.
$+1.3k
Izumi Raquel E.
$+598
Bushnell Laura I.
$+1.2k
Hwang Sooin
$+316.5
Lowe Christopher P.
$+4k
Seelenberger Alexander A.
$+5k
Hamdy Ahmed Md
$+5k
Thomas Tom C
$+1.3k
Lee John H.
$+508.6
Mcdonald Andrew I
$+12.4k
View All Transactions

During the last 3 months Vincerx Pharma Inc insiders have not bought any shares, and have not sold any shares. The stock price has dropped by 96% over this period (open performance analysis).

The last transaction was made on Aug 11, 2023 by Seelenberger Alexander A. , who bought 10k USD worth of VINC shares.

Sold
0-3
months
0 USD
0
3-6
months
0 USD
0
6-9
months
0 USD
0
9-12
months
0 USD
0
Bought
0-3
months
No Insider Transactions
0
0 USD
3-6
months
No Insider Transactions
0
0 USD
6-9
months
No Insider Transactions
0
0 USD
9-12
months
No Insider Transactions
0
0 USD

Vincerx Pharma Inc
Insider Trading Chart

Vincerx Pharma Inc
Insiders Performance

1 Week Later 1 Month Later 3 Months Later 6 Months Later 1 Year Later
Average Return
Median Return
Win Rate

Vincerx Pharma Inc
Last Insider Transactions

Global
Insiders Monitor

Vincerx Pharma Inc
Glance View

Market Cap
303.3k USD
Industry
Biotechnology

Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. The company is headquartered in Palo Alto, California and currently employs 56 full-time employees. The company went IPO on 2020-03-10. The Company’s small molecule drug program includes VIP152, which is a highly selective, clinical-stage positive transcription elongation factor-beta/cyclin-dependent kinase 9 (PTEFb/CDK9) inhibitor. The firm's antibody-drug conjugate (ADC) platform includes VIP943 (targeting CD123) and VIP924 (targeting CXCR5), which are ADC compounds addressing known and novel oncology targets. The Company’s bioconjugation program also includes VIP236, which is a small molecule drug conjugate (SMDC) for solid tumors.

VINC Intrinsic Value
Not Available

What is Insider Trading?

Insider trading refers to the buying or selling of a company’s stock by individuals with access to non-public, material information about the company.

While legal insider trading occurs when insiders follow disclosure rules, illegal insider trading involves trading based on confidential information and is prohibited by law.

Why is Insider Trading Important?

It isn't a coincidence that corporate executives seem to always buy at the right times. After all, they have access to every bit of company information you could ever want.

However, the fact that company executives have unique insights doesn't mean that individual investors are always left in the dark. Insider trading data is out there for all who want to use it.

Peter Lynch

Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.

Back to Top